Sponsor

DKMS Group gGmbH

Germany Kressbach 1, Weilheim, 72072 Tuebingen, Germany

About the sponsor

Research activity centres on allogeneic haematopoietic cell transplantation, with interest in improving transplant outcomes through conditioning regimens that support engraftment and immune tolerance.

Engraftment support
Immunosuppressive conditioning
Overall survival

The sponsor’s clinical focus in this area is closely linked to post-transplant recovery and long-term transplant success.

About Specializations

DKMS Group gGmbH runs clinical trials in conditions such as Graft versus host disease, Acute graft versus host disease, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Graft versus host disease+1

Not recruiting

Registered drugNo placebo

Comparison of Post-Transplant Cyclophosphamide versus Anti-T Lymphocyte Immunoglobulin for Prevention of Graft versus Host Disease in Patients Receiving Unrelated Donor Transplantation

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide
Sponsor:DKMS Group gGmbH

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →